The Health Shadow Price, β c

Mar 10, 2017 by in PHARMACY Comments Off on The Health Shadow Price, β c

(1) University of South Australia, Adelaide, Australia   Abstract This chapter introduces five concepts central to this book. The opportunity cost of a strategy in an institutional setting is identified…

read more

Conclusion

Mar 10, 2017 by in PHARMACY Comments Off on Conclusion

(1) University of South Australia, Adelaide, Australia   Abstract The concluding chapter presents the guide for regulators to playing and winning the new drug reimbursement game. The results from the…

read more

The Clinical Value of Innovation

Mar 10, 2017 by in PHARMACY Comments Off on The Clinical Value of Innovation

(1) University of South Australia, Adelaide, Australia   Abstract The term “innovation” is used in a number of different ways in pharmaceutical regulation processes. In this chapter I address the…

read more

The Shadow Price, λ

Mar 10, 2017 by in PHARMACY Comments Off on The Shadow Price, λ

(1) University of South Australia, Adelaide, Australia   Abstract In countries such as Australia, the UK and Canada, regulators are required to select a decision threshold that is a signal…

read more
Get Clinical Tree app for offline access